Actemra OPTION Trial Shows Benefit In RA Patients In Combination With Methotrexate
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III trial, published in The Lancet, supports the use of Roche’s interleukin-6 inhibitor for rheumatoid arthritis.